New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Raportul

Știri verificate despre finanțări, sedii centrale și leadership de la cele mai inovatoare companii din lume

3 rapoarte și mai multe

Actualizat zilnic cu ultimele informații de piață

AdvanCell Raises $315M Series D for Targeted Alpha Therapies

AdvanCell closed an oversubscribed, upsized $315 million Series D led by Ally Bridge Group and co-led by Alpha Wave to advance ADVC001 toward Phase 3 and expand U.S. manufacturing.

AdvanCell Raises $112M in Series C

AdvanCell, a HealthTech company based in San Francisco, CA, has raised $112M in Series C at a $700M valuation led by Deerfield Management, Logos Capital.

Fundraising News Team

AdvanCell raises $112M Series C at $700M valuation

AdvanCell raises $112M in Series C at $700M valuation. Radionuclide cancer therapies...

Editorial Team

Feb 1, 2025

0 min read•$112M

Pagina 1

Afișare 3 rapoarte • Pagina 1 • Categorie: all

Rămâneți înaintea pieței

Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.